Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Jim Roof who wrote (935)	5/12/1998 4:40:00 PM
From: mesaone	Read Replies (1) \| Respond to of 1432

I believe the testing on the baboon was done at the Barrow Neurological Institute in Scottsdale, AZ. In the Abbott licensing agreement, Biotime retains the rights to Hextend for "non-normothermic (less than 12 c)" uses and in total body washout applications. One of their goals is to become the leading force in low temp. medicine and surgery. I understand that they have also successfully frozen hamsters (partially, to -3c) and brought them back. They have completely frozen rat skin down to liquid nitrogen temps and rewarmed it and sewn it back onto a rat and had the skin survive long term. this could show that it might be possible to freeze and bank skin tissue for burn victims (using Hetafreeze)